Evidence map›Paper›PMID 35321882›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients.

Bo Zhai, Karen Clarke, David L Bauer, Krissy K Moehling Geffel, Saran Kupul, Lucas J Schratz, M Patricia Nowalk, Anita K McElroy, James B McLachlan, Richard K Zimmerman and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Bo ZhaiDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-3536-0105
Karen ClarkeDepartment of Family Medicine, University of Pittsburgh, Pittsburgh, PA.
David L BauerDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA; and.
Krissy K Moehling GeffelDepartment of Family Medicine, University of Pittsburgh, Pittsburgh, PA.
Saran KupulDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
Lucas J SchratzDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
M Patricia NowalkDepartment of Family Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-1702-2690
Anita K McElroyDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
James B McLachlanDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA; and.ORCID 0000-0001-7741-391X
Richard K ZimmermanDepartment of Family Medicine, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-5941-6092
John F AlcornDepartment of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA; john.alcorn@chp.edu.
University of Pittsburgh · USChildren's Hospital of Pittsburgh · USTulane University · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse networkU01IP001035 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2016 to 2020
$7.8M
Pittsburgh Training Grant in Pediatric Pulmonary MedicineT32HL129949 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Juan Carlos Celedon · 2016 to 2026
$2.9M
Using combination adjuvants to direct and control immune responses at the intestinal mucosaU01AI124289 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI MCLACHLAN, JAMES B · 2016 to 2020
$2.4M
NCATS NIH HHS UL1 TR001857NCIRD CDC HHS U01 IP001035NHLBI NIH HHS T32 HL129949NIAID NIH HHS U01 AI124289
6 · The paper itself

Abstract

COVID-19 has had an unprecedented global impact on human health. Understanding the Ab memory responses to infection is one tool needed to effectively control the pandemic. Among 173 outpatients who had virologically confirmed SARS-CoV-2 infection, we evaluated serum Ab concentrations, microneutralization activity, and enumerated SARS-CoV-2-specific B cells in convalescent human blood specimens. Serum Ab concentrations were variable, allowing for stratification of the cohort into high and low responders. Neither participant sex, the timing of blood sampling following the onset of illness, nor the number of SARS-CoV-2 spike protein-specific B cells correlated with serum Ab concentration. Serum Ab concentration was positively associated with microneutralization activity and participant age, with participants under the age of 30 showing the lowest Ab level. These data suggest that young adult outpatients did not generate as robust Ab memory, compared with older adults. Body mass index was also positively correlated with serum Ab levels. Multivariate analyses showed that participant age and body mass index were independently associated with Ab levels. These findings have direct implications for public health policy and current vaccine efforts. Knowledge gained regarding Ab memory following infection will inform the need for vaccination in those previously infected and allow for a better approximation of population-wide protective immunity.

Indexed as

Age FactorsAntibody FormationBody Mass IndexCOVID-19Antibodies, NeutralizingAntibodies, ViralB-LymphocytesHumansOutpatientsSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35321882
PMCPMC8976825
OpenAlexW4221073027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.